SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-098564
Filing Date
2011-11-14
Accepted
2011-11-14 16:44:06
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c23936e10vq.htm 10-Q 567732
2 EX-31.1 c23936exv31w1.htm EX-31.1 9106
3 EX-31.2 c23936exv31w2.htm EX-31.2 9142
4 EX-32.1 c23936exv32w1.htm EX-32.1 2873
5 EX-32.2 c23936exv32w2.htm EX-32.2 3189
  Complete submission text file 0000950123-11-098564.txt   2129173

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT cycc-20110930.xml EX-101.INS 247411
7 EX-101 SCHEMA DOCUMENT cycc-20110930.xsd EX-101.SCH 13620
8 EX-101 CALCULATION LINKBASE DOCUMENT cycc-20110930_cal.xml EX-101.CAL 41894
9 EX-101 LABELS LINKBASE DOCUMENT cycc-20110930_lab.xml EX-101.LAB 144697
10 EX-101 PRESENTATION LINKBASE DOCUMENT cycc-20110930_pre.xml EX-101.PRE 83248
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 111203523
SIC: 2834 Pharmaceutical Preparations